OrthoPediatrics Corp's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 72/207 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 24.14.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
OrthoPediatrics Corp's Score
Industry at a Glance
Industry Ranking
72 / 207
Overall Ranking
191 / 4563
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
7
analysts
Buy
Current Rating
24.143
Target Price
+32.43%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
OrthoPediatrics Corp Highlights
StrengthsRisks
OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 80 surgical and specialized bracing systems.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 67.41% year-on-year.
Overvalued
The company’s latest PE is -8.86, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 16.80M shares, decreasing 13.54% quarter-over-quarter.
OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 80 surgical and specialized bracing systems.
Ticker SymbolKIDS
CompanyOrthoPediatrics Corp
CEOBailey (David R)
Websitehttps://www.orthopediatrics.com/
FAQs
What is the current price of OrthoPediatrics Corp (KIDS)?
The current price of OrthoPediatrics Corp (KIDS) is 17.340.
What is the symbol of OrthoPediatrics Corp?
The ticker symbol of OrthoPediatrics Corp is KIDS.
What is the 52-week high of OrthoPediatrics Corp?
The 52-week high of OrthoPediatrics Corp is 27.600.
What is the 52-week low of OrthoPediatrics Corp?
The 52-week low of OrthoPediatrics Corp is 15.280.
What is the market capitalization of OrthoPediatrics Corp?
The market capitalization of OrthoPediatrics Corp is 434.84M.
What is the net income of OrthoPediatrics Corp?
The net income of OrthoPediatrics Corp is -37.82M.
Is OrthoPediatrics Corp (KIDS) currently rated as Buy, Hold, or Sell?
According to analysts, OrthoPediatrics Corp (KIDS) has an overall rating of Buy, with a price target of 24.143.
What is the Earnings Per Share (EPS TTM) of OrthoPediatrics Corp (KIDS)?
The Earnings Per Share (EPS TTM) of OrthoPediatrics Corp (KIDS) is -1.957.